Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, November 18, 2015 2:53:38 PM
bearish 9.66
descending triangle pattern
## source: finance.yahoo.com
Wed, 11 Nov 2015 12:30:00 GMT ~ aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine for GMP Process Development and for Potential Treatment of Severe Lung Diseases
[PR Newswire] - "The molecule developed in our iMod.Fc discovery program represents a major breakthrough as the first engineered Physiocrine with advantageous pharmaceutical properties designed into our therapeutic protein, which opens up new possibilities of reaching a more diverse set of patients with severe lung diseases," said John Mendlein, Ph.D., CEO and executive chairman of aTyr Pharma.
read full: http://finance.yahoo.com/news/atyr-pharma-selects-second-ind-123000534.html
*********************************************************
Tue, 10 Nov 2015 21:26:59 GMT ~ ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151110/life8-k.html
*********************************************************
Tue, 10 Nov 2015 21:15:00 GMT ~ aTyr Pharma Announces Third Quarter 2015 Operating Results
[PR Newswire] - SAN DIEGO, Nov. 10, 2015 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, ...
read full: http://finance.yahoo.com/news/atyr-pharma-announces-third-quarter-211500806.html
*********************************************************
Tue, 10 Nov 2015 12:30:00 GMT ~ aTyr Pharma to Host Breakout Session at the 6th Annual World Orphan Drug Congress
[PR Newswire] - SAN DIEGO, Nov. 10, 2015 /PRNewswire/ -- aTyr Pharma (LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, today announced the Company's participation at the 6th Annual World Orphan Drug Congress in Geneva, Switzerland. John McKew, Ph.D., Vice President of Research, will present a talk during a clinical development breakout session at the conference beginning at 5:35pm GMT on Thursday, November 12. The talk, entitled Innovative Drug Development Process for Rare Myopathies with an Immune Component, will focus on pipeline development in the rare disease space. The World Orphan Drug Congress aims to connect the key global stakeholders in the rare disease and orphan drug communities to address the most pressing issues related to treatment options in the space.
read full: http://finance.yahoo.com/news/atyr-pharma-host-breakout-session-123000270.html
*********************************************************
Mon, 09 Nov 2015 12:30:00 GMT ~ aTyr Pharma Initiates Phase 1b/2 Clinical Trial in Patients with Early Onset FSHD
[PR Newswire] - SAN DIEGO, Nov. 9, 2015 /PRNewswire/ -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced the continued expansion of its Resolaris™ clinical program in rare myopathies with an immune component ("RMICs") by initiating a Phase 1b/2 clinical trial in patients with early onset facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments. "The initiation of our early onset FSHD Resolaris program is an important step in addressing the needs of some of the most severely effected FSHD patients," said John Mendlein, Ph.D., CEO and executive chairman of aTyr Pharma.
read full: http://finance.yahoo.com/news/atyr-pharma-initiates-phase-1b-123000184.html
*********************************************************
$LIFE charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$LIFE company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/LIFE/company-info
Ticker: $LIFE
OTC Market Place: Not Available
CIK code: not found
Company name: aTyr Pharma, Inc.
Incorporated In:
$LIFE share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$LIFE extra dd links
Company name: aTyr Pharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=LIFE+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=LIFE+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=LIFE+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/LIFE/news - http://finance.yahoo.com/q/h?s=LIFE+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/LIFE/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/LIFE/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=LIFE+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/LIFE
DTCC (dtcc.com): http://search2.dtcc.com/?q=aTyr+Pharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=aTyr+Pharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=aTyr+Pharma%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/LIFE
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/LIFE/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/LIFE/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=LIFE&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=LIFE
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/LIFE/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=LIFE+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=LIFE+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=LIFE
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=LIFE
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=LIFE+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/LIFE/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=LIFE+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/LIFE.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=LIFE
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/LIFE/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/LIFE/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/LIFE
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/LIFE
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/LIFE:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=LIFE
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=LIFE
$LIFE DD Notes ~ http://www.ddnotesmaker.com/LIFE
Recent LIFE News
- aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update • GlobeNewswire Inc. • 05/02/2024 08:00:00 PM
- aTyr Pharma to Participate in April Investor Conferences • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update • GlobeNewswire Inc. • 03/14/2024 08:00:00 PM
- aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:20:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:15:45 AM
- aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:35:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:30:22 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/02/2024 05:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 11:50:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/21/2023 05:15:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 09:11:52 PM
- aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023 • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 10:01:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/09/2023 09:42:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:11:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:06:34 PM
- aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 09:00:00 PM
- aTyr Pharma to Present at November Investor Conferences • GlobeNewswire Inc. • 11/01/2023 12:00:00 PM
- aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD • GlobeNewswire Inc. • 10/31/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 01:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 12:04:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM